Greyson International, Inc. (OTC Pink Sheets: GYSN) Announced Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care. Greyson says it’s a Clear Sign Company’s Moving Vigorously Forward after Death of Its Legendary CEO as He Had Wanted

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announced Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care.  Greyson says it’s a Clear Sign Company’s Moving Vigorously Forward after Death of Its Legendary CEO as He Had Wanted

COCONUT CREEK, Fla., September 30, 2014. — Greyson International, Inc. (OTC Pink Sheets: GYSN announced today the long-awaited TV launch of the Greyson Skin Care product line, with the patented Trilexon® topical delivery system, will be Oct. 17. It will receive four separate thirty (30) minute live TV airings that day on one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), just as the company’s late CEO Harvey Tauman had planned prior to his death in July.

The well-known TV spokesperson Andrea Tilis will present the Greyson Skin Care kit on Oct. 17 at 9:30am, 1:30pm, 4:30pm and 8:30pm on The Shopping Channel seen throughout Canada. (All times are Eastern.)

“We’re excited to be carrying out the first of many things my father had planned to do as he believed so passionately.  Our skin care products with Trilexon are infinitely more effective and longer lasting than any other cosmetics,” said his son, Richard Tauman, Director of Operations of the company, now headed by Mukesh Prasad.  The company was founded by Harvey Tauman, who had held some of the most awesome cosmetics sales records in the history of TV home shopping.

Our technology supports the skins barrier layer and maintains a specific pH level on the skin to reduce moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems once applied on the skin, it continues to emulsify and break down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

About Greyson International, Inc.

Greyson’s patented Trilexon® delivery system, in addition to cosmetic applications, may have benefits in the medical field where it’s important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. Information is available http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with company’s financial condition, ability to sell its products and compete with competitors.  Please review other factors that may affect our future results on any current or future documents we file periodically with Securities & Exchange Commission.

Contacts:

Greyson International, Inc., Mukesh Prasad 954-482-0497, President, mukesh@greysonintl.com.

Media: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com.

Greyson International Inc. Provides Update on its Energy Assets

Coconut Creek, Fla. – February 28, 2013 – Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced an update on its passive investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered oil and gas company with properties located in the country of Georgia.

“Greyson has been advised that the joint venture between Blake and the MND Group has been funded and new seismic data is being collected across all three properties. A drilling campaign is expected to commence later this year and continue through 2014.” said Greyson International Inc. CEO Harvey Tauman.

On March 12, 2012, Greyson acquired a private entity that resulted in a 3% passive ownership stake in Blake. On August 14, 2012, Blake entered into a joint venture agreement with MND Group whereby the latter received a 50% interest in Blake’s Georgian assets in exchange for assuming exploration and production costs. Under the terms of the agreement, the MND Group committed to over $100 million in capital expenditures to fund the development of the Ninotsminda, Manavi and Norio assets.

According to an independent report issued by Netherland, Sewell & Associates Inc. and Oilfield Production Consultants, these properties could have significant oil and gas reserves. More information about these assets can be found on Blake’s website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International Provides Update on Prospective Biomedical Subsidiary

COCONUT CREEK, Fla. – April 10, 2013 — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Greyson is forming a subsidiary that will have a business plan which will target the multi-billion dollar pharmaceutical industry.

“Greyson’s management team has been diligently working to launch our new Greyson Biomedical subsidiary and commercialize Trilexon® Delivery System in potentially enormous medical end markets,” said Greyson International Inc. CEO Harvey Tauman. “After demonstrating efficacy in topical applications in OTC products, our goal is to license our patented technology to companies interested in improving efficacy of their existing products   or creating altogether new products.

Greyson International’s patented Trilexon® technology (U.S. Patent 8,268,335) combines a cationic emulsifying agent, oil soluble liquid polymer and naturally occurring lactate buffer system to dramatically improve the topical delivery of active ingredients. Unlike normal delivery agents, the patented formulation effectively delivers active ingredients to the skin at a more desirable pH level to enhance delivery/efficacy.

“We believe there is a lot of potential for Trilexon® Delivery System within the biomedical industry,” added CEO Harvey Tauman. “With more durable and stable delivery of active ingredients, we see potential in prescription products that promote healing, restore damaged cells, and relieve topical pain, as well as topical OTC products like pain relievers, eczema treatment, anti-itch creams, burn relief products, or sunscreens etc. Our team is working diligently to prove these claims and launching the new subsidiary in the near future in order to generate significant long-term value for our shareholders.”

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International Provides an Update on its Operations

Greyson International Provides an Update on its Operations

COCONUT CREEK, Fla.–(June 10, 2013)–Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced the sale of a portion of its interest in Blake Oil & Gas Limited (“Blake”), a privately owned, Guernsey registered oil and Gas Company with operations in the country of Georgia. The proceeds of approximately $1 million will be used to aggressively pursue retail distribution deals for its breakthrough Trilexon® powered products, as well as market Greyson Bio medical’s technology to potential licensees in the pharmaceutical industry.

Covered by U.S. Patent 8,268,335, Greyson International’s Trilexon® technology combines a cationic emulsifying agent, oil soluble liquid polymer and natural occurring lactate buffer system to dramatically improve the topical delivery of active ingredients in both the cosmetics and pharmaceutical industries.

“The sale of a portion of our interest in Blake provides us with the funding necessary to unlock the enormous potential in our breakthrough Trilexon® delivery technology across multiple end markets,” said Greyson International Inc. CEO Harvey Tauman. “We believe that Trilexon® will play a vital role in both the hypercompetitive cosmetics industry, where companies are always looking for a competitive edge, and the pharmaceutical industry where the larger players are facing so-called patent cliffs, and are looking for new ways to extend patent lives.”

Management will provide additional details about these programs as they are implemented over the coming months.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

 

Greyson International, Inc. announces its shares have officially become “DTC-Eligible”

Coconut Creek, Fla. – October 15, 2012– Greyson International, Inc. (GYSN.PK) has received notification from the Depository Trust & Clearing Corporation (“DTCC”) that its shares now have full service eligibility.

Greyson International CEO Harvey Tauman says “Now that our patent has been officially issued, our company can continue the process of shifting from a research and development company into a revenue-generating company. In accordance with our master plan of becoming a full reporting company we are pleased to announce that our securities now have the benefit of DTCC’s depository services. We are requesting that our shareholders notify their brokers of this important development and request that their shares be deposited with DTCC”.

About Greyson International, Inc.

Greyson’s main asset is its recently patented Trilexon® delivery system. It also holds an investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, Oil and Gas Company.  The Trilexon® delivery system precisely delivers key ingredients to the appropriate areas through “messengers” in order to achieve higher effectiveness and more noticeable results. The Trilexon® system creates a fine surface which is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time; ensuring that the skin receives treatment at a constant steady pace to give the skin a healthy and youthful look. We believe that Trilexon® will have benefits in the medical field and wherever it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. announces that today it filed to become DTC-Eligible, and in addition wants to invite investors to join its conference call tomorrow afternoon.

Coconut Creek, Fla. – September 19, 2012 – Greyson International, Inc. (GYSN.PK) filed today with the Depository Trust Company (“DTC”) to have its shares become “DTC-Eligible”.  This process, once effective, allows Greyson’s securities to have the benefit of DTC’s depository services.

Greyson will be holding an investor conference call on Thursday September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of active ingredients in most topical applications in today’s cosmetic and over-the-counter drug applications. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. Announces Details of its Investor Conference Call and its Updated Website

Coconut Creek, Fla. – September 14, 2012 – Greyson International, Inc. (GYSN.PK) will be holding an investor conference call  on September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

Greyson International CEO Harvey Tauman, “In addition to recent developments, we are proud to announce that we have updated our website (www.greysonintl.com), and encourage everyone to look at the new investor presentation to get a preview of the exciting things going on at Greyson.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. Receives Its Issue Date and Patent Number from the U.S. Patent and Trademark Office for its Breakthrough Trilexon® Delivery System Technology

Coconut Creek, Fla. – August 30, 2012– Greyson International, Inc. (GYSN.PK) announced today that it has received its issue date and Patent number from the U.S. Patent and Trademark Office.  The Patent will be issued on September 18, 2012 and the Patent Number is 8,268,335.

The Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said “We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

The patent is classified as a “Utility” patent and, according to the US Patent Office; a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

 

† Trilexon® is a registered trademark of Greyson International, Inc.

 

Greyson International, Inc. Provides Additional Information In Regards to its Oil & Gas Investment

Coconut Creek, Fla. – August 24, 2012 – Greyson International, Inc. (GYSN.PK) announced today additional information in regards to its investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, oil and gas company.

Earlier this year Greyson acquired a private entity that owned 630,690 shares of Blake in exchange for restricted shares of Greyson’s common stock.  Each member of that entity was issued Greyson’s shares based upon their percentage of ownership in that entity.

Greyson International is not an operator of that business.  Its interest is solely as an investor. Although its shares of ownership haven’t changed, its percentage can vary depending upon the outstanding shares of Blake. Its ownership is currently at 3%.

Blake has recently entered into a Joint Venture arrangement to further exploit its Oil and Gas Assets in Georgia. Under terms of the agreement, its partner has committed over $100,000,000 in funding to further develop its oil and gas activities in the Country of Georgia. According to independent studies, these properties have been reported to have significant oil and gas reserves.  For more information please visit their website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International, Inc. Announces Details of its Investor Conference Call and its Updated Website

Coconut Creek, Fla. – September 14, 2012 – Greyson International, Inc. (GYSN.PK) will be holding an investor conference call  on September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

Greyson International CEO Harvey Tauman, “In addition to recent developments, we are proud to announce that we have updated our website (www.greysonintl.com), and encourage everyone to look at the new investor presentation to get a preview of the exciting things going on at Greyson.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Trilexon® is a registered trademark of Greyson International, Inc.